SeekingAlpha · Aug 14, 2026
Stratec SE ADR (STSEY) Q2 2026 Earnings Call Transcript
Stratec SE ADR (STSEY) Q2 2026 Earnings Call August 14, 2026 8:00 AM EDTCompany ParticipantsJan Keppeler - Head of Investor Relations, Sustainability &...
ST
NYSE · STSEY
Stratec SE
Healthcare · Medical - Devices
$5.51
Up+$0.00 (+0.00%)
Updated Sep 25, 2026, 10:39 AM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.55B
- P/E ratio
- 18.5
- Dividend yield
- 2.55%
- 52-week range
- — – —
- Volume
- 100
- Avg. volume
- 9
Price performance
STSEY price history
1M range · 0 trading sessions · Daily adjusted prices
STSEY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest STSEY news
The latest Smart Investors Daily articles mentioning STSEY.
Stock researchCompany · Overview
STSEY research
Overview
Company profile and research snapshot.
Company profile
STRATEC SE UNSP/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 21, 2026 | BERENBERG | Buy | — |
| Sep 3, 2026 | BAADER EUROPE | Buy | — |
| Aug 28, 2026 | METZLER EQUITIES | Buy | — |
| Aug 14, 2026 | BAADER EUROPE | Buy | — |
| Aug 14, 2026 | MWB RESEARCH AG | Hold | — |
News briefing
No generated briefing is available yet.
Yahoo · Jun 23, 2026
Stratec Annual General Meeting Resolves Dividend and Approves all Proposed Resolutions
BIRKENFELD, GERMANY - June 23, 2026 (NEWMEDIAWIRE) - Shareholders at today's Annual General Meeting of STRATEC SE (Frankfurt: SBS; Prime Standard) approved all agenda items submitted for resolution for resolution with clear majorities. As propose...
SeekingAlpha · Jan 21, 2026
Stratec SE ADR (STSEY) Presents at 25th German Corporate Conference - Slideshow
Yahoo · Dec 5, 2025
Why The Narrative Around Stratec Is Shifting As Growth Expectations Are Tempered
Stratec's latest update leaves its fair value steady at €32.42 per share, while a slightly lower discount rate of 6.47% suggests a more measured, yet still supportive, view of the stock's risk profile. With long term revenue growth assumptions holding at about 5.55%, the revised price target reflects tempered optimism rather than a shift in the core investment narrative. Stay tuned to see how you can monitor these nuanced target moves so you remain aligned with the evolving story around...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
